Shares of Allurion Technologies on Friday surged a day after the company said it received positive results about the effectiveness of its gastric balloon in combination with a low dose of the ...

US stocks look set to open lower in Friday's trading session but are still in a position to close out the week higher for the first time in over a month. The Dow Jones Industrial Average futures were ...

Chardan notes that Allurion has announced additional data evaluating the use of its Allurion Balloon in combination with patients be treated ...

Ouster reported quarterly losses of 48 cents per share which beat the analyst consensus estimate of 59 cents per share. The ...

U.S. stock futures declined on Friday after tumbling in trade on Thursday. Futures of all four indices were lower in ...

Roth MKM keeps a Buy rating and $16 price target on Allurion Technologies (ALUR) after its initial results from Allurion Program-GLP-1 combo.

Allurion Technologies' gastric balloon and Novo Nordisk's semaglutide achieved 20.3% weight loss in a trial. Read more here.

Neogen® Corporation will issue its third-quarter earnings release before the opening of the market on Wednesday, April 9, 2025. Executives from the company will host a webcast and conference call ...

Planet Labs PBC , a leading provider of daily data and insights about Earth, today released first light images from its Pelican-2 satellite of the Port of Laem Chabang in Eastern Thailand, the primary ...

Research analysts at Roth Capital dropped their Q1 2025 EPS estimates for Allurion Technologies in a research note issued to investors on Wednesday, March 5th. Roth Capital analyst J. Wittes now ...